Experimental drug shows remarkable effectiveness against hard-to-treat cancers
A recent clinical study revealed promising results for an experimental drug called <strong>setidegrasib</strong>, which has been able to slow the growth of certain types of cancer and reduce tumors in several patients. This drug represents a significant step in modern medicine aimed at tackling challenging oncological treatments.